| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |